Taprizosin (also known as UK-338,003) is an alpha1A-adrenoceptor antagonist that was developed for the treatment of benign prostatic hyperplasia.
MedKoo Cat#: 127172
Name: Taprizosin mesylate
CAS#: 358632-25-4 (mesylate)
Chemical Formula: C26H30N6O7S2
Exact Mass: 602.1617
Molecular Weight: 602.68
Elemental Analysis: C, 51.82; H, 5.02; N, 13.94; O, 18.58; S, 10.64
The following data is based on the product molecular weight 602.68 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |